When EEG matters in cognitive decline — identifying reversible causes, narrowing rapidly progressive dementia, and clarifying atypical presentations.
EEG is not part of the routine workup for typical Alzheimer's-type dementia, but it is the single most useful test in specific situations — particularly when reversible causes need to be excluded.
Non-convulsive seizures, autoimmune encephalitis, and metabolic or toxic encephalopathy can all look like dementia clinically. EEG is the most sensitive way to detect them — and they are treatable when caught early.
When cognitive decline develops over weeks to months rather than years, EEG findings (such as periodic sharp-wave complexes in Creutzfeldt-Jakob disease, or focal slowing in limbic encephalitis) significantly narrow the differential.
Fluctuating cognition, episodes of unresponsiveness, sudden behavioural changes, or features that do not fit typical Alzheimer's may prompt EEG to look for an alternative explanation.
The most important question EEG answers in dementia workup is “is there something else going on that we can treat?” — rather than confirming a particular type of dementia. That focus on reversibility is what makes the test worth doing when it is indicated.
Not every patient with memory concerns needs an EEG. These are the scenarios where it adds the most value.
EEG does not diagnose dementia type on its own, but certain patterns point strongly toward particular conditions.
Confusion, fluctuating responsiveness, or apparent rapid cognitive decline can be driven by ongoing subclinical seizures. EEG shows continuous epileptiform activity that would otherwise be invisible at the bedside. Treatment can produce striking recovery.
In sporadic CJD, EEG often shows characteristic periodic sharp-wave complexes that, in the right clinical setting, are highly supportive of the diagnosis alongside MRI and cerebrospinal fluid markers.
Hepatic, uraemic, or other metabolic encephalopathy classically shows triphasic waves and diffuse slowing. The pattern responds to correction of the underlying cause.
Subacute memory loss with psychiatric features, often in adults under 60, may show temporal focal slowing or epileptiform discharges. Identifying this early matters because immune therapy can reverse the syndrome.
In moderate to advanced Alzheimer's, EEG commonly shows generalised slowing and loss of the normal posterior dominant rhythm. These findings are not specific to Alzheimer's and EEG cannot diagnose it on its own — but a strikingly normal EEG in a patient with advanced cognitive symptoms can prompt reconsideration of the diagnosis.
No. Standard dementia assessment relies on history, cognitive testing, blood tests, and brain imaging (CT or MRI). EEG is reserved for specific situations — rapidly progressive decline, suspicion of seizures contributing to cognitive symptoms, or atypical presentations where reversible causes need to be excluded.
EEG cannot diagnose Alzheimer's on its own. Generalised slowing and loss of the normal posterior background rhythm are common in moderate to advanced disease, but these findings are not specific. EEG is most useful for ruling out treatable mimics that can look like Alzheimer's clinically.
The most important reason is to rule out reversible causes. Non-convulsive seizures, autoimmune encephalitis, and metabolic encephalopathy can all present as confusion, memory loss, or apparent dementia. These conditions are treatable when identified early, and EEG is the most sensitive tool to detect them.
Rapidly progressive dementia describes cognitive decline that develops over weeks to months rather than years. EEG can show specific patterns (such as periodic sharp-wave complexes in Creutzfeldt-Jakob disease, or focal slowing in autoimmune limbic encephalitis) that significantly narrow the diagnosis when combined with imaging and lumbar puncture findings.
Sometimes yes. If clinical suspicion of seizures or encephalopathy remains high after a normal routine EEG, a repeat recording or a sleep-deprived EEG significantly increases the chance of detecting subtle abnormalities. Your neurologist will weigh the clinical picture and decide.
Same-day reporting. Specialist evaluation of reversible mimics and atypical presentations. Bondi Junction.